oral glp-1 weight loss Patients taking an experimental drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other FDA UPDATE: A new oral

doi: 10.1016/s0753-3322(03)00043-x 280 TrachoothamD.LuW.OgasawaraM

Other less common but possible side effects include headaches, increased heart rate, dizziness, and fatigue

Multivariate Behav Res (2011) 46(3):399424

10.1161/STROKEAHA.120.032621 2 BakkerM

Women using oral contraceptives should discuss the need for alternative or additional contraceptive methods during tirzepatide initiation and dose escalation

ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)